We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-0.13%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$7.41B
AUM Growth
-$1.63B
Cap. Flow
-$1.27B
Cap. Flow %
-17.2%
Top 10 Hldgs %
9.76%
Holding
2,951
New
679
Increased
670
Reduced
594
Closed
919

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$60.6M
2
CSGP icon
CoStar Group
CSGP
+$57.8M
3
ED icon
Consolidated Edison
ED
+$52.3M
4
DE icon
Deere & Co
DE
+$44.5M
5
EXC icon
Exelon
EXC
+$42.1M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$483M
2
AMZN icon
Amazon
AMZN
+$366M
3
MRNA icon
Moderna
MRNA
+$123M
4
ETR icon
Entergy
ETR
+$44.9M
5
LIN icon
Linde
LIN
+$43.7M

Sector Composition

Rank Sector Weight
1 Technology 16.98%
2 Industrials 10.54%
3 Consumer Discretionary 9.76%
4 Financials 9.11%
5 Healthcare 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICLR icon
2351
Icon
ICLR
$13.3B
-19,380
Closed -$4.01M
IDN icon
2352
Intellicheck
IDN
$59.8M
-60,413
Closed -$506K
IDXX icon
2353
PUT
Idexx Laboratories
IDXX
$43.9B
-2,000
Closed -$1.26M
IFF icon
2354
CALL
International Flavors & Fragrances
IFF
$21.5B
-10,000
Closed -$1.5M
IHI icon
2355
iShares US Medical Devices ETF
IHI
$3.49B
-31,164
Closed -$1.88M
IIIV icon
2356
i3 Verticals
IIIV
$301M
-8,017
Closed -$242K
IJR icon
2357
iShares Core S&P Small-Cap ETF
IJR
$111B
-553
Closed -$62K
IJS icon
2358
iShares S&P Small-Cap 600 Value ETF
IJS
$8.33B
-1,429
Closed -$151K
IMO icon
2359
Imperial Oil
IMO
$66.8B
-18,826
Closed -$572K
IMNM icon
2360
Immunome
IMNM
$3.24B
-12,800
Closed -$221K
IMVT icon
2361
PUT
Immunovant
IMVT
$9.16B
-107,300
Closed -$1.13M
INBK icon
2362
First Internet Bancorp
INBK
$255M
-10,798
Closed -$335K
INGN icon
2363
Inogen
INGN
$149M
-19,377
Closed -$1.26M
INGR icon
2364
Ingredion
INGR
$6.74B
-8,067
Closed -$730K
INO icon
2365
Inovio Pharmaceuticals
INO
$122M
-5,711
Closed -$635K
INSP icon
2366
Inspire Medical Systems
INSP
$1.8B
-8,034
Closed -$1.55M
INTA icon
2367
Intapp
INTA
$3.16B
-29,180
Closed -$817K
IPAR icon
2368
Interparfums
IPAR
$3.7B
-13,140
Closed -$946K
IPO icon
2369
Renaissance IPO ETF
IPO
$152M
-3,248
Closed -$215K
IQ icon
2370
iQIYI
IQ
$1.01B
-84,378
Closed -$1.31M
IRBT
2371
DELISTED
iRobot
IRBT
-15,035
Closed -$1.4M
IRM icon
2372
Iron Mountain
IRM
$36.3B
-8,013
Closed -$339K
IRON icon
2373
Disc Medicine
IRON
$3.06B
-543
Closed -$105K
IRTC icon
2374
iRhythm Holdings
IRTC
$4.24B
-19,584
Closed -$1.3M
ITUB icon
2375
Itaú Unibanco
ITUB
$82.4B
-71,789
Closed -$314K

Similar funds

Michael Gelband's Q3 2021 Portfolio in Review

As of Q3 2021, Michael Gelband held 2,951 positions worth $7.41B, down 18% from $9.04B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Michael Gelband withdrew a net $1.27B in Q3 2021, closing 919 positions and reducing 594 holdings. Its most notable exit was Amazon, an estimated $366M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Michael Gelband opened a new position in Advanced Micro Devices worth $61M.

  • Michael Gelband's largest Q3 2021 buy was Advanced Micro Devices: 592,990 shares worth $61M.
  • Michael Gelband added most to CoStar Group in Q3 2021, an estimated $57.8M increase.
  • Michael Gelband's biggest Q3 2021 reduction was Microsoft, cutting an estimated $483M.
  • Michael Gelband fully exited Amazon in Q3 2021, selling an estimated $366M.
  • Michael Gelband's ten largest holdings make up 9.8% of its $7.41B portfolio in Q3 2021.
  • Michael Gelband opened 679 new positions and closed 919 in Q3 2021.
  • Michael Gelband's portfolio value fell 18% quarter-over-quarter to $7.41B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.